210
Views
5
CrossRef citations to date
0
Altmetric
Brief Reports

The Association Between Stimulant, Opioid, and Multiple Drug Use on Behavioral Health Care Utilization in a Safety-Net Health System

, MD, MPH, , MSPH, , MD, , MSPH, PhD & , MD, MPH
Pages 407-412 | Received 12 Aug 2014, Accepted 01 Dec 2014, Published online: 27 Oct 2015

REFERENCES

  • Binswanger IA, Takahashi TA, Bradley K, Dellit TH, Benton KL, Merrill JO. Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death. J Stud Alcohol Drugs. 2008;69:924–932.
  • Cai R, Crane E, Poneleit K, Paulozzi L. Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. J Pain Palliat Care Pharmacother. 2010;24:293–297.
  • Hendrickson RG, Cloutier R, McConnell KJ. Methamphetamine-related emergency department utilization and cost. Acad Emerg Med. 2008;15:23–31.
  • Kassed CA, Levit KR, Hambrick MM. Hospitalizations Related to Drug Abuse, 2005: Statistical Brief #39. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research; 2006.
  • London JA, Utter GH, Battistella F, Wisner D. Methamphetamine use is associated with increased hospital resource consumption among minimally injured trauma patients. J Trauma. 2009;66:485–490.
  • Richards JR, Bretz SW, Johnson EB, Turnipseed SD, Brofeldt BT, Derlet RW. Methamphetamine abuse and emergency department utilization. West J Med. 1999;170:198–202.
  • Dausey DJ, Desai RA. Psychiatric comorbidity and the prevalence of HIV infection in a sample of patients in treatment for substance abuse. J Nerv Ment Dis. 2003;191:10–17.
  • Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571–583.
  • Vasica G, Tennant CC. Cocaine use and cardiovascular complications. Med J Aust. 2002;177:260–262.
  • Restrepo CS, Carrillo JA, Martinez S, Ojeda P, Rivera AL, Hatta A. Pulmonary complications from cocaine and cocaine-based substances: imaging manifestations. Radiographics. 2007;27:941–956.
  • Peterson PL, Roszler M, Jacobs I, Wilner HI. Neurovascular complications of cocaine abuse. J Neuropsychiatry Clin Neurosci. 1991;3:143–149.
  • Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse and the kidney. QJM. 2000;93:147–152.
  • Westover AN, Nakonezny PA, Haley RW. Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend. 2008;96:49–56.
  • Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579–581.
  • Merikangas KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behaviors. 1998;23:893–907.
  • Swendsen J, Conway KP, Degenhardt L, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction. 2010;105:1117–1128.
  • Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518.
  • French MT, Fang H, Balsa AI. Longitudinal analysis of changes in illicit drug use and health services utilization. Health Serv Res. 2011;46:877–899.
  • Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48:43–51.
  • Kidorf M, Disney ER, King VL, Neufeld K, Beilenson PL, Brooner RK. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend. 2004;74:115–122.
  • Murri R, Fantoni M, Del Borgo C, et al. Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. J Acquir Immune Defic Syndr. 1999;22:461–466.
  • McGeary KA, French MT. Illicit drug use and emergency room utilization. Health Serv Res. 2000;35(1 Pt 1):153–169.
  • Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Rep. 1993;108:492–500.
  • Palepu A, Horton NJ, Tibbetts N, Meli S, Samet JH. Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. Addiction. 2004;99:361–368.
  • Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006;84:188–194.
  • Cunningham CO, Sohler NL, Cooperman NA, Berg KM, Litwin AH, Arnsten JH. Strategies to improve access to and utilization of health care services and adherence to antiretroviral therapy among HIV-infected drug users. Subst Use Misuse. 2011;46:218–232.
  • Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001;161:85–91.
  • D'Aunno T. Linking substance abuse treatment and primary health care. In: Egertson, JA, Fox, DM, Leshner, AI, Eds. Treating drug abusers effectively. Blackwell, Malden, MA; 1997:311–331.
  • Sørensen TA, Bentsen K, Eghøje K, Orholm M, Høybye G, Offersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet. 1984;324:241–244.
  • Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572–1585.
  • Furlanello F, Serdoz LV, De Ambroggi L, Cappato R. Drug abuse in cardiovascular diseases. In: Verster, JC, Brady, K, Galanter, M, and Conrod, PJ, eds. Drug Abuse and Addiction in Medical Illness. New York, NY: Springer; 2012:393–406.
  • Martinotti G, Carli V, Tedeschi D, et al. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addict Behav. 2009;34:790–793.
  • Hakansson A, Schlyter F, Berglund M. Associations between polysubstance use and psychiatric problems in a criminal justice population in Sweden. Drug Alcohol Depend. 2011;118:5–11.
  • Nuzum R, Fund C. Denver Health: A High-Performance Public Health Care System. xx: Commonwealth Fund; 2007.
  • Gabow P, Eisert S, Wright R. Denver Health: a model for the integration of a public hospital and community health centers. Ann Intern Med. 2003;138:143–149.
  • Centers for Disease Control and Prevention. International Classification of Diseases, Classification of Diseases, Functioning, and Disability, Ninth Revision (ICD-9). Available at: http://www.cdc.gov/nchs/icdicd9.htm. Published 2009. Accessed August 10, 2014.
  • Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34:1273–1302.
  • Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend. 2008;97:226–230.
  • Billings J, Mijanovich T. Improving the management of care for high-cost Medicaid patients. Health Aff. 2007;26:1643–1654.
  • Rittenhouse DR, Shortell SM. The patient-centered medical home: will it stand the test of health reform? JAMA. 2009;301:2038–2040.
  • Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19:1111–1117.
  • Halkitis PN, Kutnick AH, Slater S. The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states. J Health Psychol. 2005;10:545–558.
  • Cunningham CO, Sohler NL, Berg KM, Shapiro S, Heller D. Type of substance use and access to HIV-related health care. AIDS Patient Care STDs. 2006;20:399–407.
  • Tucker JS, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573–580.
  • Sharpe TT, Lee LM, Nakashima AK, Elam-Evans LD, Fleming PL. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health. 2004;29:117–127.
  • Crisp BR, Williams M, Timpson S, Ross MW. Medication compliance and satisfaction with treatment for HIV disease in a sample of African-American crack cocaine smokers. AIDS Behav. 2004;8:199–206.
  • McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953–1959.
  • Carey TS, Crotty KA, Morrissey JP, et al. AHRQ Comparative Effectiveness Reviews. Future Research Needs for the Integration of Mental Health/Substance Abuse and Primary Care: Identification of Future Research Needs from Evidence Report/Technology Assessment No. 173. Rockville, MD: Agency for Healthcare Research and Quality; 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.